Cenegermin-Bkbj — Active Pharmaceutical Ingredient

Cenegermin-Bkbj is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: SOLUTION. Routes: OPHTHALMIC.

This content is for informational purposes only. Always consult a healthcare professional.

Cenegermin-Bkbj (1 brand name, 1 dosage form, 1 route)

Available dosage forms: SOLUTION.

Routes of administration: OPHTHALMIC.

Brand Names

  • OXERVATE

Indications and Usage

OXERVATE® (cenegermin-bkbj) ophthalmic solution 0.002% is indicated for the treatment of neurotrophic keratitis.

Contraindications

None.

Mechanism of Action

Nerve growth factor is an endogenous protein involved in the differentiation and maintenance of neurons, which acts through specific high-affinity (i.e., TrkA) and low-affinity (i.e. p75NTR) nerve growth factor receptors in the anterior segment of the eye to support corneal innervation and integrity.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.